Stocks:
5,169
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.09T
24h Vol:
$8.59B
Dominance:
MSFT:4.90%
Stocklytics Platform
Asset logo for symbol CYRX
CryoPort
CYRX
51
$9.84arrow_drop_down4.83%-$0.50

Performance History

Chart placeholder
Key Stats
Open$10.18
Prev. Close$10.34
EPS-2.48
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$540.84M
PE Ratio-
LOWHIGH
Day Range9.83
10.37
52 Week Range9.00
23.50
Ratios
P/B Ratio1.86
Revenue$233.25M
Operating M. %-38.98%
Earnings$0.00
Earnings Growth %-166.75%
EBITDA Margin %-17.72%
ROE %-21.87%
EPS-2.48

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

info
There's no data available for Analyst Forecast

Analyst Ratings

info
There's no data available for Analyst Ratings

Correlated Companies

PRICE$155.88
24H (%)arrow_drop_up0.12%
24H ($)$0.19
MARKET CAP$183.16B
PRICE$104.23
24H (%)arrow_drop_down0.76%
24H ($)-$0.80
MARKET CAP$139.97B
PRICE$222.10
24H (%)0.00%
24H ($)-$0.01
MARKET CAP$139.46B
PRICE$319.01
24H (%)arrow_drop_down2.84%
24H ($)-$9.33
MARKET CAP$133.12B

About CryoPort (CYRX)

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Sector
Industrials
Industry
Integrated Freight & Logistics
CEO
Mr. Jerrell W. Shelton
Headquarters
Brentwood
Employees
1000
Exchange
NASDAQ
add CryoPort  to watchlist

Keep an eye on CryoPort

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is CryoPort 's (CYRX) price per share?

The current price per share for CryoPort (CYRX) is $9.84. The stock has seen a price change of -$0.5 recently, indicating a -4.84% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for CryoPort (CYRX)?

For CryoPort (CYRX), the 52-week high is $23.5, which is 138.82% from the current price. The 52-week low is $9, the current price is 9.33% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is CryoPort (CYRX) a growth stock?

CryoPort (CYRX) has shown an average price growth of 0.41% over the past three years. It has received a score of 17 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CryoPort as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is CryoPort (CYRX) stock price performance year to date (YTD)?

As of the latest data, CryoPort (CYRX) has a year-to-date price change of -36.35%. Over the past month, the stock has experienced a price change of -29.96%. Over the last three months, the change has been -35.18%. Over the past six months, the figure is -38.27%. Looking at a longer horizon, the five-year price change stands at -46.95%.

help
Is CryoPort (CYRX) a profitable company?

CryoPort (CYRX) has a net income of -$99.59M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 35.6% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -38.98% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $233.26M, although specific revenue growth data is currently not available. The gross profit is $83.04M. Operating income is noted at -$58.64M. Furthermore, the EBITDA is -$41.33M.

help
What is the market capitalization of CryoPort (CYRX)?

CryoPort (CYRX) has a market capitalization of $540.85M. The average daily trading volume is 785.2K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level